Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported ...

Cracow University of Technology, CUT Doctoral School, Faculty of Chemical Engineering and Technology, Warszawska 24, Cracow 31-155, Poland ...

The fraction of the dose excreted as the glucuronide ... of the present study strongly suggest that the lowering of serum bilirubin concentration by phenobarbital in the hyperbilirubinemic infant ...

High blood levels of unconjugated bilirubin (UCB) is most widely known as the causative agent of jaundice, a yellowing of the skin and eyes. Neonatal jaundice has been described in the medical ...

Atienza et al 25 recently studied specifically the intermittent nature of irregular activity from a different perspective. The original definition of CFAEs includes 2 different features: electrogram ...